Aandelen in “Tandheelkundige laboratoria”

Aandeel Datum Koers Evolutie
vlag Viemed Healthcare Inc 30/10 9,670 USD
-2,81% 		-2,81%
vlag Vita 34 AG 29/10 2,790 EUR
0,00% 		0,00%

Nieuws over “Tandheelkundige laboratoria”

28/10 · Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance · Persbericht

28/10 · Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance · Persbericht

23/10 · Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 · Persbericht

22/10 · Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential · Persbericht

22/10 · Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 · Persbericht

21/10 · Labcorp Declares Quarterly Dividend · Persbericht

20/10 · Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option · Persbericht

19/10 · Current Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension · Persbericht

16/10 · PHSC Plc - Resignation of Non-Executive Chair · Persbericht

15/10 · Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health · Persbericht

13/10 · Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test · Persbericht

7/10 · AMN Healthcare to Hold Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026 · Persbericht

6/10 · AMN Healthcare Research Links Hospital Digital Investment to Better Patient Experience · Persbericht

1/10 · Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials · Persbericht

30/09 · Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026 · Persbericht

29/09 · Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform · Persbericht

22/09 · Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026 · Persbericht

22/09 · PHSC Plc - Results of AGM · Persbericht

22/09 · PHSC Plc - Trading Update · Persbericht

21/09 · Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics · Persbericht

18/09 · mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide · Persbericht

Mijn selecties